![]() |
University of Liège, Pathology Tower (BC-3), Sart-Tilman, B-4000 Liège, BELGIUM Phone : +32-4-366.72.75 Fax : +32-4-366.29.36 |
Our Publications
Noel A., Jost M., Lambert V., Lecomte J. and Rakic J.-M.; Anti-angiogenic therapy of exudative age-related macular degeneration : current progress and emerging concepts,
Kuiper E., Roestenberg P., Ehlken C., Lambert V., Bloys van Treslong-de Groot H., Lyons K., Agostini H.-J., Rakic J.-M., Klaassen I., Van Noorden C., Goldschmeding R. and Schlingemann R.; Angiogenesis is not impaired in connective tissue growth factor (CTGF) knock out mice,
Jost M., Maillard C., Lecomte J., Lambert V., Tjwa M., Blaise P., Alvarez Gonzalez M.-L., Bajou K., Blacher S., Motte P., Humblet C., Defresne M.-P., Thiry M., Frankenne F., Gothot A., Carmeliet P., Rakic J.-M., Foidart J.-M. and Noël A. ;Tumoral and choroidal vascularization: differential cellular mechanisms involving plasminogen activator inhibitor type I (PAI-1).
Rakic, J.M., Lambert, V., Noel, A. and Foidart, J.M.; Author Response: PAI-1 and Ocular Angiogenesis
Lambert, V., Wielockx, B., Munaut, C., Galopin, C., Jost, M., Takeshi, I., Werb, Z., Baker, A., Libert, C., Foidart, J.M., Noel, A. and Rakic, J.M.; Severe inhibition of choroidal neovascularization in mice with a combined deficiency of MMP-2 and MMP-9 genes,
Rakic, J.M., Lambert, V., Devy, L., Luttun, A., Carmeliet, P., Claes, C., Nguyen, L., Foidart, J.M., Noël, L. and Munaut, C.; Placental growth factor, a member of VEGF Family, Contributes to the Development of Choroidal Neovascularization
Lambert, V., Munaut, C., Bajou, K., Carmeliet, P., Gerard, R., Declerck, P., Gils, A., Claes, C., Foidart, J.-M., Noël, A. and Rakic, J.-M. ; Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I.
Rakic, J.M., Maillard, C., Jost, M., Bajou, K. , Masson, V., Devy, L., Lambert, V., and Foidart, J.M. and Noël, A.; Role of plasminogen activator-plasmin system in tumor angiogenesis.
Rakic, J.M., Lambert,V., Munaut, C., Bajou, K., Peyrollier, K., Alvarez-Gonzalez,M.L., Carmeliet, P., Foidart, J.M. and Noël, A. ; Mice without uPA, tPA or Plasminogen genes are resistant to experimental choroidal neovascularization.
Rakic, J.M., Lambert, V., Deprez, M., Foidart, J.-M., Noël, A. and Munaut, C.; Estrogens reduce the expression of YKL-40 in the retina : implications for eye and joint diseases.
Lambert*, V., Munaut*, C., Noël, A., Werb, Z., Foidart, J.-M. and Rakic, J.-M. ; MMP-9 Contributes to Choroidal Neovascularization. * first autors.
Munaut*, C., Lambert*, V., Noël, A., Frankenne, F., Deprez, M., Foidart, J.-M. and Rakic, J.-M.; Presence of estrogen receptor type beta in human retina. * first autors.
Lambert, V., Munaut, C., Noël, A., Frankenne, F., Bajou, K., Gerard, R., Carmeliet, P., Defresne, M.P., Foidart, J.-M. and Rakic, J.-M.; Influence of plasminogen activator Inhibitor Type I on Choroidal Neovascularization.
Noel, A., Bajou, K., Masson, V., Devy, L., Frankenne, F., Rakic, J.M., Lambert, V., Carmeliet, P. and Foidart J. M.; Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1.
Trends in Molecular Medicine 2007 13(8):354.352
Journal of Histochemistry and Cytochemistry 2007 July 11.
American Journal of Pathology 2007 Aug 23.
IOVS Online, 29 Sep 2003. Letter to the editor.
FASEB J. 2003 Dec;17(15):2290-2. Epub 2003 Oct 16.
other link
Investigative Ophthalmology & Visual Science, 44(7), 3186-3193, 2003.
Investigative Ophthalmology & Visual Science, 44(6), 2791-2797, 2003.
Cellular and Molecular Life Sciences, 60, 463-473, 2003.
Investigative Ophthalmology & Visual Science, 44(4), 1732-1739, 2003.
Investigative Ophthalmology & Visual Science, 44(4), 1740-1746, 2003.
American Journal of Pathology, 161(4): 1247-1253, 2002.
British Journal of Ophthalmology 85(7): 877-882, 2001
FASEB Journal Vol.15 April: 1021-1027, 2001
Fibrinolysis & Proteolysis 13 (6):220-225, 1999.